1. Anxiety after Sympathectomy in patients with primary palmar hyperhidrosis may prolong the duration of compensatory hyperhidrosis
- Author
-
Jing-Hai Zhou, Kai Qian, Qunyou Tan, Ru-Wen Wang, Yong-Geng Feng, and Bo Deng
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Time Factors ,Side effect ,medicine.medical_treatment ,lcsh:Surgery ,Compensatory hyperhidrosis ,Anxiety ,lcsh:RD78.3-87.3 ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Postoperative Complications ,Forearm ,Medicine ,Humans ,Hyperhidrosis ,Sympathectomy ,Retrospective Studies ,Proportional hazards model ,business.industry ,General Medicine ,lcsh:RD1-811 ,Middle Aged ,Cardiac surgery ,medicine.anatomical_structure ,Treatment Outcome ,Cardiothoracic surgery ,lcsh:Anesthesiology ,030220 oncology & carcinogenesis ,Anesthesia ,Surgery ,Female ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Palmar hyperhidrosis ,Research Article ,Follow-Up Studies - Abstract
Background Compensatory hyperhidrosis (CH) is a frequent side effect after sympathectomy for the treatment of primary palmar hyperhidrosis. We determined the effects of demographic and clinical factors which may increase the duration of CH (DCH). Methods One hundred twenty-two patients who had undergone sympathectomies from 2014 to 2016 were retrospectively reviewed. Anxiety was evaluated using the State and Trait Anxiety Inventory score. Follow-up evaluations continued until CH remitted. A Cox proportional hazards model was used to determine the association between DCH and variables. Results DCH ranged from 5 to 27 weeks (median, 11.47 weeks). Severe CH (HR = 0.318, 95% CI, 0.136–0.741) and exacerbated anxiety 1 month post-operatively (HR = 0.816, 95% CI, 0.746–0.893) may prolong CH. A positive correlation between post-operative anxiety and DCH was common in patients with moderate or severe CH, and in cases with forearm CH. Conclusions Pre- and post-operative anxiety should be evaluated, and anti-anxiety treatment is offered to patients with moderate-to-severe CH to shorten the DCH. Electronic supplementary material The online version of this article (10.1186/s13019-018-0736-3) contains supplementary material, which is available to authorized users.
- Published
- 2018